These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 24548854)
21. Upregulation of BDNF mRNA and trkB mRNA in the nigrostriatal system and in the lesion site following unilateral transection of the medial forebrain bundle. Venero JL; Vizuete ML; Revuelta M; Vargas C; Cano J; Machado A Exp Neurol; 2000 Jan; 161(1):38-48. PubMed ID: 10683272 [TBL] [Abstract][Full Text] [Related]
22. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat. Moore AE; Cicchetti F; Hennen J; Isacson O Exp Neurol; 2001 Dec; 172(2):363-76. PubMed ID: 11716560 [TBL] [Abstract][Full Text] [Related]
23. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease. Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494 [TBL] [Abstract][Full Text] [Related]
24. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909 [TBL] [Abstract][Full Text] [Related]
25. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease. Howells FM; Russell VA; Mabandla MV; Kellaway LA Behav Brain Res; 2005 Dec; 165(2):210-20. PubMed ID: 16159673 [TBL] [Abstract][Full Text] [Related]
26. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures. Kääriäinen TM; Piltonen M; Ossola B; Kekki H; Lehtonen S; Nenonen T; Lecklin A; Raasmaja A; Männistö PT Brain Res; 2008 Apr; 1203():149-59. PubMed ID: 18329008 [TBL] [Abstract][Full Text] [Related]
27. A rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic acid into the striatum. Yoon HH; Kim YH; Shin ES; Jeon SR J Korean Med Sci; 2014 Nov; 29(11):1555-61. PubMed ID: 25408589 [TBL] [Abstract][Full Text] [Related]
28. Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy. Liang XB; Liu XY; Li FQ; Luo Y; Lu J; Zhang WM; Wang XM; Han JS Brain Res Mol Brain Res; 2002 Dec; 108(1-2):51-9. PubMed ID: 12480178 [TBL] [Abstract][Full Text] [Related]
29. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease. Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of glutamate and acetylcholine release in behavioral improvement induced by electroacupuncture in parkinsonian rats. Sun Z; Jia J; Gong X; Jia Y; Deng J; Wang X; Wang X Neurosci Lett; 2012 Jun; 520(1):32-7. PubMed ID: 22583765 [TBL] [Abstract][Full Text] [Related]
31. Deprenyl induces GFAP immunoreactivity in the intact and injured dopaminergic nigrostriatal system but fails to counteract axotomy-induced degenerative changes. Revuelta M; Venero JL; Machado A; Cano J Glia; 1997 Oct; 21(2):204-16. PubMed ID: 9336235 [TBL] [Abstract][Full Text] [Related]
32. Electro-acupuncture stimulation protects dopaminergic neurons from inflammation-mediated damage in medial forebrain bundle-transected rats. Liu XY; Zhou HF; Pan YL; Liang XB; Niu DB; Xue B; Li FQ; He QH; Wang XH; Wang XM Exp Neurol; 2004 Sep; 189(1):189-96. PubMed ID: 15296849 [TBL] [Abstract][Full Text] [Related]
33. Regulation of axotomy-induced dopaminergic neuron death and c-Jun phosphorylation by targeted inhibition of cdc42 or mixed lineage kinase. Crocker SJ; Hayley SP; Smith PD; Mount MP; Lamba WR; Callaghan SM; Slack RS; Park DS J Neurochem; 2006 Jan; 96(2):489-99. PubMed ID: 16336220 [TBL] [Abstract][Full Text] [Related]
34. Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats. Jia J; Sun Z; Li B; Pan Y; Wang H; Wang X; Yu F; Liu L; Zhang L; Wang X Behav Brain Res; 2009 Dec; 205(1):214-8. PubMed ID: 19549545 [TBL] [Abstract][Full Text] [Related]
35. The pesticide fipronil injected into the substantia nigra of male rats decreases striatal dopamine content: A neurochemical, immunohistochemical and behavioral study. Bharatiya R; Bratzu J; Lobina C; Corda G; Cocco C; De Deurwaerdere P; Argiolas A; Melis MR; Sanna F Behav Brain Res; 2020 Apr; 384():112562. PubMed ID: 32070689 [TBL] [Abstract][Full Text] [Related]
36. The effects of unilateral 6-OHDA lesion in medial forebrain bundle on the motor, cognitive dysfunctions and vulnerability of different striatal interneuron types in rats. Ma Y; Zhan M; OuYang L; Li Y; Chen S; Wu J; Chen J; Luo C; Lei W Behav Brain Res; 2014 Jun; 266():37-45. PubMed ID: 24613235 [TBL] [Abstract][Full Text] [Related]
37. Relationships among rat ultrasonic vocalizations, behavioral measures of striatal dopamine loss, and striatal tyrosine hydroxylase immunoreactivity at acute and chronic time points following unilateral 6-hydroxydopamine-induced dopamine depletion. Grant LM; Barnett DG; Doll EJ; Leverson G; Ciucci M Behav Brain Res; 2015 Sep; 291():361-371. PubMed ID: 26026785 [TBL] [Abstract][Full Text] [Related]
38. In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats. Sarre S; Yuan H; Jonkers N; Van Hemelrijck A; Ebinger G; Michotte Y J Neurochem; 2004 Jul; 90(1):29-39. PubMed ID: 15198664 [TBL] [Abstract][Full Text] [Related]
39. Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra. Sengstock GJ; Olanow CW; Dunn AJ; Barone S; Arendash GW Exp Neurol; 1994 Nov; 130(1):82-94. PubMed ID: 7529713 [TBL] [Abstract][Full Text] [Related]
40. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]